Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
NECLIFE
NECLIFE

Nectar Lifesciences Ltd.

NSE: NECLIFE
BSE: 532649
Sector: Healthcare
Industry: Pharmaceuticals
10.34-0.4 (-3.72%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

21.2 / 100

Value Score

9.6 / 100

Price Momentum Score

23.8 / 100

QVM Score

4.6 / 100

Key Metrics

Market Cap
200.87
P/E (TTM)
-0.82
P/B
0.34
P/S (TTM)
32.64
EV/EBITDA
-
CAPE (5Y)
-
ROE (TTM)
-46.16
ROCE (TTM)
-23.67
ROA (TTM)
-26.61
Avg 3Y ROE
-
Earnings 3Y CAGR
-131.63
Sales 3Y CAGR
-84.04
Sales 5Y CAGR
-66.86
Debt/Equity
0.00
Consensus TP
-
Strong Buy %
-
Promoter Holding
51.84
Pledged %
0.00

Share Price

Track Nectar Lifesciences Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

10.34-0.4 (-3.72%)
-23.97% in past 1 year
1 Week returns: -1.90 %
Low
10.2
High
11.6
1 Month returns: -6.34 %
Low
10.0
High
11.6
1 Year returns: -22.49 %
Low
9.2
High
22.5
3 Year CAGR: -22.96 %
Low
9.2
High
56.5
5 Year CAGR: -18.01 %
Low
9.2
High
56.5
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Nectar Lifesciences Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median

PE TTM of -0.82 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -102.69%

What is P/E Ratio?

Median: 30.47
Value -0.82
-0.82614.73
Consistently pays dividend

The company has not missed dividend payments once in the last 5 financial years

What is Dividend streak?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative
Weak price momentum

Price Momentum score of 23.8 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term

What is Price Momentum score?

23.8 / 100

Company's earnings are of low quality

Earnings quality score of 28.3 indicates that the company's earnings are of low quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

28.3 / 100

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral
Not enough talking points with neutral stance
Stock in ASM list
The stock has been places in Additional Surveillance Measure (ASM) list (LTASM - I (13)).
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.209948.

Financial Snapshot

See detailed analysis

Multi-year trends for Nectar Lifesciences Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
01k1k2k2k1.5 K CrMar 20231.7 K CrMar 20241.7 K CrMar 20250.0 CrMar 2026
Profit After Tax FY
-0k-0k-0k00k25.0 CrMar 2022-24.2 CrMar 20235.0 CrMar 2024-113.7 CrMar 2025
ROE FY
-15%-10%-5%0%5%2.3%Mar 2022-2.2%Mar 20230.5%Mar 2024-11.2%Mar 2025
EBITDA FY
-0k00k0k0k0k158.5 CrMar 202253.9 CrMar 2023153.1 CrMar 2024-26.5 CrMar 2025

Nectar Lifesciences Ltd. Shareholding Pattern

Quarterly breakdown of Nectar Lifesciences Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Total Promoter
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
44.53
44.53
44.53
44.91
44.91
51.84
51.84
51.84
Indian Promoter
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
55.80
44.53
44.53
44.53
44.91
44.91
51.84
51.84
51.84
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
2.90
2.90
2.90
2.62
2.62
2.62
2.46
1.52
1.67
1.49
16.14
16.01
16.09
16.01
16.03
16.13
16.99
16.63
3.26
0.75
1.80
0.96
0.69
6.36
4.63
4.25
4.42
Mutual Funds / UTI
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
-
-
-
-
-
-
-
-
-
-
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
FII
2.90
2.90
2.90
2.62
2.62
2.62
2.46
1.52
1.67
1.49
16.12
15.99
16.07
16.00
16.02
16.12
16.98
16.60
3.24
0.73
1.65
0.82
0.62
0.52
0.60
0.50
0.50
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.13
0.13
0.04
5.82
4.01
3.73
3.90
Non-Institution
41.30
41.30
41.30
41.58
41.58
41.58
41.74
42.68
42.53
42.72
28.06
28.19
28.11
28.18
28.16
28.06
27.21
27.57
40.94
54.72
53.67
54.50
54.41
48.73
43.52
43.90
43.74
Bodies Corporate
16.95
16.94
16.69
16.71
16.70
16.75
17.24
16.83
16.41
16.44
1.61
1.54
1.57
1.55
1.68
1.77
1.59
1.45
7.54
10.98
6.97
5.30
4.84
4.30
3.67
2.94
3.03
Others (incl. Retail)
No. of shareholders
24.35
39,760
24.36
47,022
24.61
46,907
24.87
46,538
24.88
47,201
24.83
53,087
24.50
54,884
25.85
55,837
26.12
63,795
26.28
63,697
26.45
62,738
26.65
64,228
26.54
62,688
26.63
61,389
26.48
60,093
26.29
60,567
25.62
59,749
26.12
58,044
33.40
66,463
43.74
69,110
46.70
68,894
49.20
71,631
49.57
76,153
44.43
77,823
39.85
74,557
40.96
73,568
40.71
72,083

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Nectar Lifesciences Ltd. shares as reported to NSE and BSE.

NameMonthTransactionHolding % pre transactionAverage priceQty.Transaction value
RAMAN GOYAL
Promoter Group
December-2024
Market Purchase (Acquisition)
19th Dec 2024
0.00 %₹ 44.374.00 lac₹ 1.77 cr

Corporate Actions

History of Nectar Lifesciences Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

  1. Others
    Ex-date: 24th Dec 2025Announced on: 3rd Dec 2025
    "On Market Tender Offer."
  2. Dividend₹ 0.05/share
    Record date: 14th Sep 2020Ex-date: 11th Sep 2020
    Announced on: 29th Jul 2020
  3. Dividend₹ 0.05/share
    Record date: 21st Sep 2019Ex-date: 19th Sep 2019
    Announced on: 25th May 2019
  4. Dividend₹ 0.05/share
    Record date: 21st Sep 2018Ex-date: 19th Sep 2018
    Announced on: 28th May 2018
  5. Dividend₹ 0.05/share
    Record date: 21st Sep 2017Ex-date: 20th Sep 2017
    Announced on: 27th Jun 2017

Company Profile

Overview of Nectar Lifesciences Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Nectar Lifesciences Limited is an India-based pharmaceutical company. The Companys business areas include active pharmaceutical ingredients (APIs) and intermediates, formulations/finished dosage formulations (FDF), menthol and mint derivatives, and empty hard gelatin capsules. The Company is engaged...
Key personnel
Mr. Amit Chadah
Chief Executive Officer
Mr. Sanjaymohan Singh Rawat
Compliance Officer, Company Secretary
Mr. Sanjiv GoyalD
Executive Chairman of the Board, Managing Director
Mr. Sushil KapoorD
Additional Director( Whole-Time Director), Director (Finance)
Dr. Kuldip Kumar BhasinD
Independent Non-Executive Director
Dr. Indu Pal Kaur, Ph.D.D
Independent Non-Executive Director
Dr. Rupinder TewariD
Independent Non-Executive Director
Dr. Rupinder TewariD
Independent Non-Executive Director
Incorporated on
27 Jun 1995
Last Annual
31 Mar 2026
Last Interim
30 Jun 2026
No. of Employees
111
IPO date
19 Jul 2005
Free Float
8,61,32,179
Phone no.
+911723047777
Address
Sco 38-39,, Sector 9-D, CHANDIGARH, 160009, India

Frequently Asked Questions

What is the current share price of Nectar Lifesciences Ltd.?
The current share price of Nectar Lifesciences Ltd. is ₹ 10.34 as of 23 Oct 2026.
What is the market capitalisation of Nectar Lifesciences Ltd.?
The market capitalisation of Nectar Lifesciences Ltd. stands at ₹ 200.87 Cr.
What is the PE ratio of Nectar Lifesciences Ltd.?
The Price-to-Earnings (PE) ratio of Nectar Lifesciences Ltd. is -0.82 as of the latest trailing twelve months data.
What is the ROE and ROCE of Nectar Lifesciences Ltd.?
Nectar Lifesciences Ltd. has a Return on Equity (ROE) of -46.16% and a Return on Capital Employed (ROCE) of -23.67% as per the latest financial reports.
What is the 52-week high and low of Nectar Lifesciences Ltd.?
The 52-week high of Nectar Lifesciences Ltd. is - and the 52-week low is -.
What is the dividend yield of Nectar Lifesciences Ltd.?
The dividend yield of Nectar Lifesciences Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Nectar Lifesciences Ltd.?
Foreign Institutional Investors (FII) hold 0.50%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 40.71% of Nectar Lifesciences Ltd. shares.
What sector does Nectar Lifesciences Ltd. belong to?
Nectar Lifesciences Ltd. operates in the Healthcare sector.
What is the beta of Nectar Lifesciences Ltd.?
The beta of Nectar Lifesciences Ltd. is 0.95, indicating its price volatility relative to the broader market. Over the past 1 year, Nectar Lifesciences Ltd. has delivered an absolute return of -23.63%.
What is the RSI of Nectar Lifesciences Ltd.?
The 14-day Relative Strength Index (RSI) of Nectar Lifesciences Ltd. is 43.91, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.